Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clearance for Quidel's redesigned Helicobacter pylori test:

This article was originally published in Clinica

Executive Summary

US rapid diagnostics manufacturer Quidel has received clearance from the US FDA to market an updated version of its point-of-care test for H pylori infection. According to Quidel, the redesigned test produces quicker results and is performed on a smaller blood sample compared with the company's existing test. QuickVue One-Step H Pylori was originally cleared by the FDA in February 1996. Over 80% of peptic ulcer disease cases are believed to be associated with H pylori infection.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079287

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel